ninety-three stage iii and iv patients with non-hodgkin 's lymphoma were randomized to either high dose cvp ( cyclophosphamide 1500 mg/m2 i.v . day 1 , vincristine 1.4 mg/m2 day 1 , and prednisone 40 mg/m2 orally days 1-10 ) or high dose cavp ( cyclophosphamide 1000 mg/m2 i.v . day 1 , doxorubicin 45 mg/m2 i.v . day 1 , vincristine and prednisone as above ) .
C0056633
cvp
C0010583
cyclophosphamide